Form D · Pharmaceuticals

VIA Pharmaceuticals, Inc.

San Francisco, CA · CIK 0001003929

Offering snapshot reported Nov 17, 2010 · SEC filing

Reported sold
$3.2M
Offering amount: $12M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 29, 2010
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.6M$3.2MMar 30, 2010: $1,250,000.00Mar 30, 2010Nov 17, 2010: $3,201,397.00Nov 17, 2010

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,250,000 → $3,201,397

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 17, 2010Amendment$3,201,397$1,951,397vs Mar 30, 20102SEC filing
Mar 30, 2010Initial$1,250,000No comparison2SEC filing
Jul 13, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jun 18, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jul 11, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-57801
Offering includes $6,000,000 of notes (of which $3,201,397 have been sold) and warrants to purchase (i) 17,647,059 shares of common stock at $.17 per share, and (ii) 42,253,521 shares of common stock at $.071 per share.

Source: Form D, filed Nov 17, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mark Nk Bagnall Director
Lawrence K Cohen Director, Executive
Fred B Craves Director
Douglass B Given Director
David T Howard Director
John R Larson Director
James G Stewart Executive
Rebecca A Taub Executive
Karen S Wright Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
750 Battery Street Suite 330
San Francisco, CA, 94111